Literature DB >> 15941569

Epstein Barr virus specific T-cells generated from unstable human atherosclerotic lesions: Implications for plaque inflammation.

Onno J de Boer1, Peter Teeling, Mirza M Idu, Anton E Becker, Allard C van der Wal.   

Abstract

OBJECTIVE: T-cell activation is an essential feature of atherosclerotic plaque inflammation, which eventually may lead to plaque rupture. In this study, we investigated if EBV, a common herpes virus, is capable of stimulating atherosclerotic plaque derived T-cells and thus could contribute to atherosclerotic plaque inflammation.
METHODS: Plaque derived T-cell cultures were established from symptomatic carotid atherosclerotic plaques of 19 patients. B-cells from the same patients were transformed with EBV to form lymphoblastoid cell lines (B-LCL) that served as antigen presenting cells. The proliferation of T-cells in the presence of autologous B-LCL was analyzed using 3H-thymidine incorporation. The presence of EBV in atherosclerotic material was analyzed by PCR.
RESULTS: Of the 19 cell obtained T-cell cultures, 11 responded to EBV (58%, mean stimulation index: 10.1+/-3.1). PCR analysis showed that EBV DNA was present in 15 of the tissue samples (79%). All the specimens that contained EBV responding T-cells also contained EBV. EBV specific T-cells secreted granzymes, as indication of functional cytotoxic potential.
CONCLUSIONS: EBV-specific cytotoxic T-cells and EBV DNA can be frequently observed in human atherosclerotic plaques. This suggests that a T-cell response against EBV could contribute to plaque inflammation, and thus to the onset of acute clinical symptoms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15941569     DOI: 10.1016/j.atherosclerosis.2005.05.001

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  Human Coronary Plaque T Cells Are Clonal and Cross-React to Virus and Self.

Authors:  Roshni Roy Chowdhury; Jessica D'Addabbo; Xianxi Huang; Stefan Veizades; Koki Sasagawa; David M Louis; Paul Cheng; Jan Sokol; Annie Jensen; Alexandria Tso; Vishnu Shankar; Ben Shogo Wendel; Isaac Bakerman; Grace Liang; Tiffany Koyano; Robyn Fong; Allison N Nau; Herra Ahmad; Jayakrishnan Gopakumar; Robert Wirka; Andrew S Lee; Jack Boyd; Y Joseph Woo; Thomas Quertermous; Gunsagar Singh Gulati; Siddhartha Jaiswal; Yueh-Hsiu Chien; Charles Kwok Fai Chan; Mark M Davis; Patricia K Nguyen
Journal:  Circ Res       Date:  2022-04-18       Impact factor: 23.213

2.  Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.

Authors:  Anja Thormann; Melinda Magyari; Nils Koch-Henriksen; Bjarne Laursen; Per Soelberg Sørensen
Journal:  J Neurol       Date:  2016-10-03       Impact factor: 4.849

3.  New approaches to the concept of primary prevention of atherosclerosis.

Authors:  Monique A Ford; Thomas G Allison; Amir Lerman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-02

4.  Epstein-barr virus-induced gene-3 is expressed in human atheroma plaques.

Authors:  Sybille Kempe; Philipp Heinz; Enikö Kokai; Odile Devergne; Nikolaus Marx; Thomas Wirth
Journal:  Am J Pathol       Date:  2009-07       Impact factor: 4.307

5.  Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk.

Authors:  W James Waldman; Marshall V Williams; Stanley Lemeshow; Philip Binkley; Denis Guttridge; Janice K Kiecolt-Glaser; Deborah A Knight; Katherine J Ladner; Ronald Glaser
Journal:  Brain Behav Immun       Date:  2007-09-12       Impact factor: 7.217

Review 6.  Vigilance on New-Onset Atherosclerosis Following SARS-CoV-2 Infection.

Authors:  Ya Liu; Hai-Gang Zhang
Journal:  Front Med (Lausanne)       Date:  2021-01-20

Review 7.  Adaptive Immune Responses in Human Atherosclerosis.

Authors:  Silvia Lee; Benjamin Bartlett; Girish Dwivedi
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923

8.  Decreased plasma IL-35 levels are related to the left ventricular ejection fraction in coronary artery diseases.

Authors:  Yingzhong Lin; Ying Huang; Zhengde Lu; Cheng Luo; Ying shi; Qiutang Zeng; Yifeng Cao; Lin Liu; Xiaoyan Wang; Qingwei Ji
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.